Similarly, Ishikawa cancer stem cells expressing CD133 had greater mitochondrial mass than CD133-ve cells (1.3-fold increase, p ≤ 0.001, Figure 1d), suggesting they may be more sensitive to mitochondrial inhibitors, such as metformin, than bulk tumour cells. Here, PROM1 is linked to neoplasm.